Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies

Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engi...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical research Vol. 35; no. 11; pp. 220 - 12
Main Authors Majumder, Subhabrata, Jones, Michael T., Kimmel, Michael, Alphonse Ignatius, Arun
Format Journal Article
LanguageEnglish
Published New York Springer US 01.11.2018
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Methods Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [ 13 C- 1 H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Results Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. Conclusion The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs.
AbstractList Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Methods Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [ 13 C- 1 H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Results Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. Conclusion The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs.
PurposeFc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs.MethodsHere, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [13C-1H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments.ResultsUnlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution.ConclusionThe overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs.
Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [ C- H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs.
Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [.sup.13C-.sup.1H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs.
Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach to achieve desired effector function and clinical efficacy of therapeutic mAbs. It remains debatable, however, whether molecular engineering either by changing glycosylation patterns or by amino acid mutation in Fc domain could impact the higher order structure of Fc domain potentially leading to increased aggregation propensities in mAbs. Methods Here, we use NMR fingerprinting analysis of Fc domains, generated from selected Pfizer mAbs with similar glycosylation patterns, to address this question. Specifically, we use high resolution 2D [.sup.13C-.sup.1H] NMR spectra of Fc fragments, which fingerprints methyl sidechain bearing residues, to probe the correlation of higher order structure with the storage stability of mAbs. Thermal calorimetric studies were also performed to assess the stability of mAb fragments. Results Unlike NMR fingerprinting, thermal melting temperature as obtained from calorimetric studies for the intact mAbs and fragments (Fc and Fab), did not reveal any correlation with the aggregation propensities of mAbs. Despite >97% sequence homology, NMR data suggests that higher order structure of Fc domains could be dynamic and may result in unique conformation(s) in solution. Conclusion The overall glycosylation pattern of these mAbs being similar, these conformation(s) could be linked to the inherent plasticity of the Fc domain, and may act as early transients to the overall aggregation of mAbs.
ArticleNumber 220
Audience Academic
Author Alphonse Ignatius, Arun
Kimmel, Michael
Majumder, Subhabrata
Jones, Michael T.
Author_xml – sequence: 1
  givenname: Subhabrata
  surname: Majumder
  fullname: Majumder, Subhabrata
  organization: Pharmaceutical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc
– sequence: 2
  givenname: Michael T.
  surname: Jones
  fullname: Jones, Michael T.
  organization: Analytical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc
– sequence: 3
  givenname: Michael
  surname: Kimmel
  fullname: Kimmel, Michael
  organization: Pharmaceutical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc
– sequence: 4
  givenname: Arun
  orcidid: 0000-0002-7342-044X
  surname: Alphonse Ignatius
  fullname: Alphonse Ignatius, Arun
  email: arun.alphonseignatius@pfizer.com
  organization: Pharmaceutical Research and Development, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30255351$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1rFTEUxYNU7Gv1D3AjA27cTL03k8zH8vFqW6GiCwVdhUzmZkiZSWoyT-h_b16nfqJkEUh-53DvOSfsyAdPjD1HOEOA5nVChE6WgG3JJUDZPmIblE1VdiA-H7ENNFyUbSPwmJ2kdAMALXbiCTuugEtZSdywLx9i6J0fi13wNsRZLy54PRXn7hvF5Ja7ItjiwhTnYdbOp8L5YjuOkcZ7sMxqT8W74IOZ7nVbv7g-DI7SU_bY6inRs4f7lH26ePNxd1Vev798u9tel0aCXEouOrIAvCFtBDTV0KIYtBC10b2mjovBNAB1jS3ZrtYotbFkhWhsy83Q8-qUvVp9b2P4uqe0qNklQ9OkPYV9UhyR11hx2WX05V_oTdjHPPZKgch5_UaNeiLlcixL1OZgqrYZ4AhYQabO_kHlM9DsTE7Fuvz-hwBXgYkhpUhW3UY363inENShTrXWqXKd6lCnarPmxcPA-36m4afiR38Z4CuQ8pcfKf7a6P-u3wFIQqos
CitedBy_id crossref_primary_10_1016_j_addr_2021_02_007
crossref_primary_10_1021_acs_analchem_9b05385
crossref_primary_10_1016_j_xphs_2022_06_014
crossref_primary_10_3389_fbioe_2023_1257665
crossref_primary_10_3390_antib8020036
crossref_primary_10_1007_s11095_022_03200_6
crossref_primary_10_1016_j_xphs_2019_10_038
crossref_primary_10_1007_s11095_019_2652_1
crossref_primary_10_1093_glycob_cwz068
Cites_doi 10.1021/bi026364g
10.1021/bi702238b
10.1021/bi002898a
10.1021/ac802575y
10.1002/pro.362
10.1016/j.tibs.2009.07.004
10.1002/jps.21104
10.1016/j.febslet.2014.01.051
10.4161/19420862.2014.985494
10.1016/j.jmr.2014.01.008
10.1002/bip.360311007
10.1021/mp500005v
10.1002/jps.23056
10.1016/j.tibtech.2014.05.005
10.1021/bi00447a048
10.1006/jmbi.1998.2556
10.1021/ci700237g
10.1021/mp400666b
10.1016/j.xphs.2017.02.007
10.1038/385787a0
10.4161/mabs.23532
10.1016/j.bbrc.2007.02.042
10.1021/ac504804m
10.1126/science.1184991
10.1007/s12104-014-9586-7
10.1126/science.1124964
10.1002/jps.23543
10.1016/j.xphs.2017.10.010
10.1021/jacs.8b00931
10.1016/S0006-3495(00)76462-9
10.1021/ja300265w
10.1021/ja072157y
10.1038/nri2747
10.1002/pro.2340
10.1021/ac404130a
10.1021/acs.analchem.7b03571
10.4049/jimmunol.1401218
10.1002/jps.23827
10.1007/s11095-015-1802-3
10.1016/0014-5793(81)80642-4
10.1073/pnas.97.15.8340
10.1093/jb/mvt095
10.1038/nrd3229
10.1038/srep32201
10.1073/pnas.1305688110
10.1016/j.molimm.2013.03.018
10.1016/j.jbiosc.2011.06.017
10.1016/S0006-3495(00)76602-1
10.1016/j.xphs.2017.08.011
10.1002/jps.21514
10.1021/ja00381a009
10.1038/nature01891
10.1021/bi00527a016
10.1016/S0022-2836(02)01250-0
10.1021/bi400232p
10.1002/biot.201000091
10.1021/mp200404c
10.1002/jps.21269
10.1016/j.molimm.2009.01.026
10.1002/pro.396
10.1016/j.str.2018.03.017
10.1080/19420862.2016.1269580
ContentType Journal Article
Copyright Springer Science+Business Media, LLC, part of Springer Nature 2018
COPYRIGHT 2018 Springer
Pharmaceutical Research is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: Springer Science+Business Media, LLC, part of Springer Nature 2018
– notice: COPYRIGHT 2018 Springer
– notice: Pharmaceutical Research is a copyright of Springer, (2018). All Rights Reserved.
DBID NPM
AAYXX
CITATION
3V.
7RV
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s11095-018-2500-8
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals
Neurosciences Abstracts
Proquest Health & Medical Complete
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Academic Eastern Edition
PubMed
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: ProQuest_Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1573-904X
EndPage 12
ExternalDocumentID A724210130
10_1007_s11095_018_2500_8
30255351
Genre Journal Article
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29O
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5VS
67N
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYOK
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABELW
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOAH
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFDYV
AFEXP
AFGCZ
AFKRA
AFLOW
AFNRJ
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AOSHJ
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IJ-
IKXTQ
IMOTQ
INH
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAK
LLZTM
LSO
M1P
M4Y
MA-
MK0
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
WOW
YCJ
YLTOR
Z45
Z5O
Z7S
Z7U
Z7V
Z7W
Z7X
Z81
Z82
Z83
Z84
Z87
Z88
Z8N
Z8O
Z8P
Z8Q
Z8R
Z8V
Z8W
Z91
Z92
ZGI
ZMTXR
ZOVNA
~KM
AACDK
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
ALIPV
H13
NPM
AAEOY
AAQLM
AAYXX
CITATION
7TK
7XB
8FK
K9.
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c505t-249ef0027eac4073d814da446cabae924dc7006618ef96a15acfef447f82cdb23
IEDL.DBID U2A
ISSN 0724-8741
IngestDate Fri Oct 25 03:15:09 EDT 2024
Wed Nov 06 08:28:51 EST 2024
Thu Feb 22 23:52:20 EST 2024
Tue Nov 12 23:30:56 EST 2024
Fri Sep 13 09:29:02 EDT 2024
Wed Oct 16 00:59:35 EDT 2024
Sat Dec 16 11:59:17 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Fc domain
differential scanning calorimetry
nuclear magnetic resonance spectroscopy
storage stability
aggregation
Fab domain
molecular fingerprinting
monoclonal antibodies
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-249ef0027eac4073d814da446cabae924dc7006618ef96a15acfef447f82cdb23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7342-044X
PMID 30255351
PQID 2112047249
PQPubID 37334
PageCount 12
ParticipantIDs proquest_miscellaneous_2112613259
proquest_journals_2112047249
gale_infotracmisc_A724210130
gale_infotracacademiconefile_A724210130
crossref_primary_10_1007_s11095_018_2500_8
pubmed_primary_30255351
springer_journals_10_1007_s11095_018_2500_8
PublicationCentury 2000
PublicationDate 2018-11-01
PublicationDateYYYYMMDD 2018-11-01
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-11-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationSubtitle An Official Journal of the American Association of Pharmaceutical Scientists
PublicationTitle Pharmaceutical research
PublicationTitleAbbrev Pharm Res
PublicationTitleAlternate Pharm Res
PublicationYear 2018
Publisher Springer US
Springer
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer
– name: Springer Nature B.V
References Teplyakov, Zhao, Malia, Obmolova, Gilliland (CR31) 2013; 56
Manikwar, Majumdar, Hickey, Thakkar, Samra, Sathish, Volkin (CR18) 2013; 102
Zhang, Hu, MacGregor, Xue, Fan, Suchecki, Liu (CR15) 2014; 86
Palmer (CR36) 2014; 241
Arbogast, Delaglio, Schiel, Marino (CR21) 2017; 89
Liu, Ren, Huang, Dankberg, Rosenfeld, Cocco (CR41) 2008; 47
Iwura, Fukuda, Yamazaki, Kanamaru, Arisaka (CR63) 2013; 155
Grevys (CR4) 2015; 194
Rose, van Berkel, van den Bremer, Labrijn, Vink, Schuurman, Parren (CR14) 2013; 5
Mittermaier, Kay (CR42) 2006; 312
Arbogast, Brinson, Formolo, Hoopes, Marino (CR22) 2016; 33
Arora, Joshi, Middaugh, Weis, Volkin (CR65) 2017; 106
Kjellsson, Sethson, Jonsson (CR57) 2003; 42
Houde, Arndt, Domeier, Berkowitz, Engen (CR13) 2009; 81
Arbogast, Brinson, Marino (CR20) 2015; 87
Hanson, Yguerabide, Schumaker (CR33) 1981; 20
Ionescu, Vlasak, Price, Kirchmeier (CR25) 2008; 97
Singh, Bandi, Jones, Mallela (CR29) 2017; 106
Teplyakov, Zhao, Malia, Obmolova, Gilliland (CR46) 2013; 56
Roberts (CR54) 2014; 32
Burkitt, Domann, O'connor (CR16) 2010; 19
Folch, Rooman, Dehouck (CR51) 2008; 48
CR3
Robustelli, Stafford, Palmer (CR35) 2012; 134
Krapp, Mimura, Jefferis, Huber, Sondermann (CR39) 2003; 325
Garber, Demarest (CR24) 2007; 355
Samra, He (CR5) 2012; 9
Moorthy, Schultz, Kim, Topp (CR49) 2014; 11
Majumdar, Manikwar, Hickey, Samra, Sathish, Bishop, Weis (CR17) 2013; 52
Dolgikh, Gilmanshin, Brazhnikov, Bychkova, Semisotnov, Venyaminov, Ptitsyn (CR58) 1981; 136
Brader, Estey, Bai, Alston, Lucas, Lantz (CR64) 2015; 12
Vermeer, Norde, van Amerongen (CR30) 2000; 79
Yagi, Zhang, Yagi-Utsumi, Yamaguchi, Iida, Yamaguchi, Kato (CR44) 2015; 9
Kamerzell, Middaugh (CR10) 2008; 97
Brandts, Hu, Lin, Mas (CR27) 1989; 28
Pace, Joshi, Esfandiary, Stadelman, Bishop, Middaugh (CR60) 2018; 107
Van Buren, Rehder, Gadgil, Matsumura, Jacob (CR55) 2009; 98
Mittermaier, Kay (CR47) 2009; 12
Chiti, Stefani, Taddei, Ramponi, Dobson (CR62) 2003; 424
Beck (CR1) 2010; 10
Nelson, Dhimolea, Reichert (CR2) 2010; 9
Calzolai, Lysek, Güntert, von Schroetter, Riek, Zahn, Wüthrich (CR59) 2000; 97
Kitevski-LeBlanc, Yuwen, Dyer, Rudolph, Luger, Kay (CR43) 2018; 140
Mittermaier, Kay (CR37) 2009; 34
Religa, Sprangers, Kay (CR45) 2010; 328
Tischenko, ZaVyalov, Medgyesi, Potekhin, Privalov (CR26) 1982; 3
Booth, Sunde, Bellotti, Robinson (CR56) 1997; 385
CR52
Nishi, Miyajima, Wakiyama, Kubota, Hasegawa, Uchiyama, Fukui (CR7) 2011; 112
Menzen, Friess (CR6) 2014; 103
Japelj, Ilc, Marušič, Senčar, Kuzman, Plavec (CR23) 2016; 6
Ito, Tsumoto (CR50) 2013; 22
Lipari, Szabo (CR38) 1982; 104
Kessler, Mronga, Müller, Moroder, Huber (CR32) 1991; 31
Viles, Donne, Kroon, Prusiner, Cohen, Dyson, Wright (CR48) 2001; 40
Wu, Kroe-Barrett, Singh, Robinson, Roberts (CR53) 2014; 588
Sekhar, Kay (CR19) 2013; 110
Kayser, Chennamsetty, Voynov, Forrer, Helk, Trout (CR40) 2010; 6
Majumdar, Esfandiary, Bishop, Samra, Middaugh, Volkin, Weis (CR8) 2015; 7
Abedini, Meng, Raleigh (CR61) 2007; 129
Boehm, Woof, Kerr, Perkins (CR34) 1999; 286
Vermeer, Norde (CR11) 2000; 78
Oganesyan, Damschroder, Woods, Cook, Wu, Dall’Acqua (CR9) 2009; 46
Chen, Brodsky, Kleemann, Latypov (CR12) 2010; 19
Sahin, Weiss, Kroetsch, King, Kessler, Das, Roberts (CR28) 2012; 101
25728213 - Anal Chem. 2015 Apr 7;87(7):3556-61
23594236 - Biochemistry. 2013 May 14;52(19):3376-89
29731233 - Structure. 2018 Jul 3;26(7):1007-1014.e2
1665090 - Biopolymers. 1991 Sep;31(10):1189-204
18161956 - J Chem Inf Model. 2008 Jan;48(1):119-27
23868852 - Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12867-74
23628091 - Mol Immunol. 2013 Nov;56(1-2):131-9
28843351 - J Pharm Sci. 2017 Dec;106(12):3486-3498
18680168 - J Pharm Sci. 2009 Sep;98(9):3013-30
25687223 - Mol Pharm. 2015 Apr 6;12(4):1005-17
9039909 - Nature. 1997 Feb 27;385(6619):787-93
10900000 - Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8340-5
24908382 - Trends Biotechnol. 2014 Jul;32(7):372-80
27578487 - Sci Rep. 2016 Aug 31;6:32201
24597564 - Anal Chem. 2014 Apr 1;86(7):3468-75
7140745 - Eur J Biochem. 1982 Sep 1;126(3):517-21
22246657 - J Pharm Sci. 2012 May;101(5):1678-87
16614210 - Science. 2006 Apr 14;312(5771):224-8
20414207 - Nat Rev Immunol. 2010 May;10(5):345-52
22263524 - Mol Pharm. 2012 Apr 2;9(4):696-707
25524268 - MAbs. 2015;7(1):84-95
18186490 - J Pharm Sci. 2008 Sep;97(9):3494-517
20811384 - Nat Rev Drug Discov. 2010 Oct;9(10):767-74
7317358 - Biochemistry. 1981 Nov 24;20(24):6842-52
25904551 - J Immunol. 2015 Jun 1;194(11):5497-508
19250681 - Mol Immunol. 2009 May;46(8-9):1750-5
10064707 - J Mol Biol. 1999 Mar 12;286(5):1421-47
20360109 - Science. 2010 Apr 2;328(5974):98-102
28212986 - J Pharm Sci. 2017 Jun;106(6):1508-1518
11023918 - Biophys J. 2000 Oct;79(4):2150-4
28937210 - Anal Chem. 2017 Nov 7;89(21):11839-11845
22381384 - J Am Chem Soc. 2012 Apr 11;134(14):6365-74
27960628 - MAbs. 2017 Feb/Mar;9(2):167-181
24530501 - FEBS Lett. 2014 Mar 18;588(6):936-41
12527303 - J Mol Biol. 2003 Jan 31;325(5):979-89
26453189 - Pharm Res. 2016 Feb;33(2):462-75
24155259 - J Biochem. 2014 Jan;155(1):63-71
23963869 - Protein Sci. 2013 Nov;22(11):1542-51
20162626 - Protein Sci. 2010 Apr;19(4):826-35
17321501 - Biochem Biophys Res Commun. 2007 Apr 13;355(3):751-7
11258885 - Biochemistry. 2001 Mar 6;40(9):2743-53
19265386 - Anal Chem. 2009 Apr 1;81(7):2644-51
25291979 - Biomol NMR Assign. 2015 Oct;9(2):257-60
21783411 - J Biosci Bioeng. 2011 Oct;112(4):326-32
17721938 - J Pharm Sci. 2008 Apr;97(4):1414-26
20512972 - Protein Sci. 2010 Jun;19(6):1191-204
20949542 - Biotechnol J. 2011 Jan;6(1):38-44
29037466 - J Pharm Sci. 2018 Feb;107(2):559-570
24816133 - Mol Pharm. 2014 Jun 2;11(6):1869-79
24382634 - J Pharm Sci. 2014 Feb;103(2):445-55
7327267 - FEBS Lett. 1981 Dec 28;136(2):311-5
17722920 - J Am Chem Soc. 2007 Sep 19;129(37):11300-1
10620303 - Biophys J. 2000 Jan;78(1):394-404
24656076 - J Magn Reson. 2014 Apr;241:3-17
12917692 - Nature. 2003 Aug 14;424(6950):805-8
18407665 - Biochemistry. 2008 May 6;47(18):5088-100
19846313 - Trends Biochem Sci. 2009 Dec;34(12):601-11
2690944 - Biochemistry. 1989 Oct 17;28(21):8588-96
23620222 - J Pharm Sci. 2013 Jul;102(7):2136-51
12525163 - Biochemistry. 2003 Jan 21;42(2):363-74
29589929 - J Am Chem Soc. 2018 Apr 11;140(14):4774-4777
23406897 - MAbs. 2013 Mar-Apr;5(2):219-28
H Kessler (2500_CR32) 1991; 31
AK Mittermaier (2500_CR47) 2009; 12
SM Singh (2500_CR29) 2017; 106
D Liu (2500_CR41) 2008; 47
Arnoldus W.P. Vermeer (2500_CR11) 2000; 78
A Teplyakov (2500_CR31) 2013; 56
SE Pace (2500_CR60) 2018; 107
A Kjellsson (2500_CR57) 2003; 42
A Teplyakov (2500_CR46) 2013; 56
AL Nelson (2500_CR2) 2010; 9
L Calzolai (2500_CR59) 2000; 97
T Menzen (2500_CR6) 2014; 103
LW Arbogast (2500_CR21) 2017; 89
A Sekhar (2500_CR19) 2013; 110
R Majumdar (2500_CR17) 2013; 52
R Majumdar (2500_CR8) 2015; 7
Veysel Kayser (2500_CR40) 2010; 6
JF Brandts (2500_CR27) 1989; 28
JL Kitevski-LeBlanc (2500_CR43) 2018; 140
MK Boehm (2500_CR34) 1999; 286
AW Vermeer (2500_CR30) 2000; 79
RM Ionescu (2500_CR25) 2008; 97
DR Booth (2500_CR56) 1997; 385
HS Samra (2500_CR5) 2012; 9
J Arora (2500_CR65) 2017; 106
2500_CR3
VM Tischenko (2500_CR26) 1982; 3
AK Mittermaier (2500_CR37) 2009; 34
CJ Roberts (2500_CR54) 2014; 32
A Grevys (2500_CR4) 2015; 194
V Oganesyan (2500_CR9) 2009; 46
F Chiti (2500_CR62) 2003; 424
G Lipari (2500_CR38) 1982; 104
B Folch (2500_CR51) 2008; 48
A Mittermaier (2500_CR42) 2006; 312
N Buren Van (2500_CR55) 2009; 98
LW Arbogast (2500_CR20) 2015; 87
W Burkitt (2500_CR16) 2010; 19
TL Religa (2500_CR45) 2010; 328
T Iwura (2500_CR63) 2013; 155
BS Moorthy (2500_CR49) 2014; 11
DA Dolgikh (2500_CR58) 1981; 136
TJ Kamerzell (2500_CR10) 2008; 97
H Nishi (2500_CR7) 2011; 112
A Beck (2500_CR1) 2010; 10
H Wu (2500_CR53) 2014; 588
B Japelj (2500_CR23) 2016; 6
AG Palmer III (2500_CR36) 2014; 241
2500_CR52
A Abedini (2500_CR61) 2007; 129
S Krapp (2500_CR39) 2003; 325
SLH Chen (2500_CR12) 2010; 19
E Sahin (2500_CR28) 2012; 101
D Houde (2500_CR13) 2009; 81
A Zhang (2500_CR15) 2014; 86
H Yagi (2500_CR44) 2015; 9
JH Viles (2500_CR48) 2001; 40
LW Arbogast (2500_CR22) 2016; 33
T Ito (2500_CR50) 2013; 22
ML Brader (2500_CR64) 2015; 12
P Manikwar (2500_CR18) 2013; 102
RJ Rose (2500_CR14) 2013; 5
DC Hanson (2500_CR33) 1981; 20
P Robustelli (2500_CR35) 2012; 134
E Garber (2500_CR24) 2007; 355
References_xml – volume: 42
  start-page: 2363
  year: 2003
  end-page: 2374
  ident: CR57
  article-title: Hydrogen exchange in a large 29 kD protein and characterization of molten globule aggregation by NMR
  publication-title: Biochemistry
  doi: 10.1021/bi026364g
  contributor:
    fullname: Jonsson
– volume: 47
  start-page: 5088
  year: 2008
  end-page: 5100
  ident: CR41
  article-title: Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation
  publication-title: Biochemistry
  doi: 10.1021/bi702238b
  contributor:
    fullname: Cocco
– volume: 40
  start-page: 2743
  issue: 9
  year: 2001
  end-page: 2753
  ident: CR48
  article-title: Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics
  publication-title: Biochemistry
  doi: 10.1021/bi002898a
  contributor:
    fullname: Wright
– volume: 81
  start-page: 2644
  issue: 7
  year: 2009
  end-page: 2651
  ident: CR13
  article-title: Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry
  publication-title: Anal Chem
  doi: 10.1021/ac802575y
  contributor:
    fullname: Engen
– volume: 19
  start-page: 826
  issue: 4
  year: 2010
  end-page: 835
  ident: CR16
  article-title: Conformational changes in oxidatively stressed monoclonal antibodies studied by hydrogen exchange mass spectrometry
  publication-title: Protein Sci
  doi: 10.1002/pro.362
  contributor:
    fullname: O'connor
– volume: 12
  start-page: 601
  issue: 34
  year: 2009
  end-page: 611
  ident: CR47
  article-title: Observing biological dynamics at atomic resolution using NMR
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2009.07.004
  contributor:
    fullname: Kay
– volume: 97
  start-page: 1414
  issue: 4
  year: 2008
  end-page: 1426
  ident: CR25
  article-title: Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies
  publication-title: J Pharm Sci
  doi: 10.1002/jps.21104
  contributor:
    fullname: Kirchmeier
– volume: 588
  start-page: 936
  issue: 6
  year: 2014
  end-page: 941
  ident: CR53
  article-title: Competing aggregation pathways for monoclonal antibodies
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2014.01.051
  contributor:
    fullname: Roberts
– volume: 7
  start-page: 84
  issue: 1
  year: 2015
  end-page: 95
  ident: CR8
  article-title: Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life
  publication-title: MAbs
  doi: 10.4161/19420862.2014.985494
  contributor:
    fullname: Weis
– volume: 241
  start-page: 3
  year: 2014
  end-page: 17
  ident: CR36
  article-title: Chemical exchange in biomacromolecules: past, present, and future
  publication-title: J Magn Reson
  doi: 10.1016/j.jmr.2014.01.008
  contributor:
    fullname: Palmer
– volume: 31
  start-page: 1189
  issue: 10
  year: 1991
  end-page: 1204
  ident: CR32
  article-title: Conformational analysis of a IgG1 hinge peptide derivative in solution determined by NMR spectroscopy and refined by restrained molecular dynamics simulations
  publication-title: Biopolymers
  doi: 10.1002/bip.360311007
  contributor:
    fullname: Huber
– volume: 11
  start-page: 1869
  year: 2014
  end-page: 1879
  ident: CR49
  article-title: Predicting protein aggregation during storage in lyophilized solids using solid state amide hydrogen/deuterium exchange with mass spectrometric analysis (ssHDX-MS)
  publication-title: Mol Pharm
  doi: 10.1021/mp500005v
  contributor:
    fullname: Topp
– volume: 101
  start-page: 1678
  issue: 5
  year: 2012
  end-page: 1687
  ident: CR28
  article-title: Aggregation and pH–temperature phase behavior for aggregates of an IgG2 antibody
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23056
  contributor:
    fullname: Roberts
– volume: 32
  start-page: 372
  issue: 7
  year: 2014
  end-page: 380
  ident: CR54
  article-title: Therapeutic protein aggregation: mechanisms, design, and control
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2014.05.005
  contributor:
    fullname: Roberts
– volume: 28
  start-page: 8588
  issue: 21
  year: 1989
  end-page: 8596
  ident: CR27
  article-title: A simple model for proteins with interacting domains. Applications to scanning calorimetry data
  publication-title: Biochemistry
  doi: 10.1021/bi00447a048
  contributor:
    fullname: Mas
– volume: 286
  start-page: 1421
  issue: 5
  year: 1999
  end-page: 1447
  ident: CR34
  article-title: The fab and fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling
  publication-title: J Mol Biol
  doi: 10.1006/jmbi.1998.2556
  contributor:
    fullname: Perkins
– volume: 48
  start-page: 119
  issue: 1
  year: 2008
  end-page: 127
  ident: CR51
  article-title: Thermostability of salt bridges versus hydrophobic interactions in proteins probed by statistical potentials
  publication-title: J Chem Inf Model
  doi: 10.1021/ci700237g
  contributor:
    fullname: Dehouck
– volume: 12
  start-page: 1005
  year: 2015
  ident: CR64
  article-title: Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies
  publication-title: Mol Pharm
  doi: 10.1021/mp400666b
  contributor:
    fullname: Lantz
– volume: 106
  start-page: 1508
  issue: 6
  year: 2017
  end-page: 1518
  ident: CR65
  article-title: Correlating the effects of antimicrobial preservatives on conformational stability, aggregation propensity, and backbone flexibility of an IgG1 mAb
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2017.02.007
  contributor:
    fullname: Volkin
– volume: 385
  start-page: 787
  issue: 6619
  year: 1997
  ident: CR56
  article-title: Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
  publication-title: Nature
  doi: 10.1038/385787a0
  contributor:
    fullname: Robinson
– volume: 5
  start-page: 219
  issue: 2
  year: 2013
  end-page: 228
  ident: CR14
  article-title: Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG
  publication-title: Mabs
  doi: 10.4161/mabs.23532
  contributor:
    fullname: Parren
– volume: 355
  start-page: 751
  issue: 3
  year: 2007
  end-page: 757
  ident: CR24
  article-title: A broad range of fab stabilities within a host of therapeutic IgGs
  publication-title: Biochemical and biophysical research communications, 2007
  doi: 10.1016/j.bbrc.2007.02.042
  contributor:
    fullname: Demarest
– volume: 87
  start-page: 3556
  issue: 7
  year: 2015
  end-page: 3561
  ident: CR20
  article-title: Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance
  publication-title: Anal Chem
  doi: 10.1021/ac504804m
  contributor:
    fullname: Marino
– volume: 328
  start-page: 98
  year: 2010
  end-page: 102
  ident: CR45
  article-title: Dynamic regulation of archaeal proteasome gate opening as studied by TROSY NMR
  publication-title: Science
  doi: 10.1126/science.1184991
  contributor:
    fullname: Kay
– volume: 9
  start-page: 257
  year: 2015
  end-page: 260
  ident: CR44
  article-title: Backbone 1 H, 13 C, and 15 N resonance assignments of the fc fragment of human immunoglobulin G glycoprotein
  publication-title: Biomolecular NMR assignments
  doi: 10.1007/s12104-014-9586-7
  contributor:
    fullname: Kato
– volume: 312
  start-page: 224
  year: 2006
  end-page: 228
  ident: CR42
  article-title: New tools provide new insights in NMR studies of protein dynamics
  publication-title: Science
  doi: 10.1126/science.1124964
  contributor:
    fullname: Kay
– volume: 102
  start-page: 2136
  issue: 7
  year: 2013
  end-page: 2151
  ident: CR18
  article-title: Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23543
  contributor:
    fullname: Volkin
– volume: 107
  start-page: 559
  year: 2018
  end-page: 570
  ident: CR60
  article-title: The use of a GroEL-BLI biosensor to rapidly assess preaggregate populations for antibody solutions exhibiting different stability profiles
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2017.10.010
  contributor:
    fullname: Middaugh
– volume: 140
  start-page: 4774
  issue: 14
  year: 2018
  end-page: 4777
  ident: CR43
  article-title: Investigating the dynamics of destabilized nucleosomes using methyl-TROSY NMR
  publication-title: J Am Chem Soc
  doi: 10.1021/jacs.8b00931
  contributor:
    fullname: Kay
– volume: 79
  start-page: 2150
  issue: 4
  year: 2000
  end-page: 2154
  ident: CR30
  article-title: The unfolding/denaturation of immunogammaglobulin of isotype 2b and its F ab and F c fragments
  publication-title: Biophys J
  doi: 10.1016/S0006-3495(00)76462-9
  contributor:
    fullname: van Amerongen
– volume: 134
  start-page: 6365
  year: 2012
  end-page: 6374
  ident: CR35
  article-title: Interpreting protein structural dynamics from NMR chemical shifts
  publication-title: J Am Chem Soc
  doi: 10.1021/ja300265w
  contributor:
    fullname: Palmer
– volume: 3
  start-page: 517
  year: 1982
  end-page: 521
  ident: CR26
  article-title: A thermodynamic study of cooperative structures in rabbit immunoglobulin G
  publication-title: FEBS J
  contributor:
    fullname: Privalov
– volume: 129
  start-page: 11300
  issue: 37
  year: 2007
  end-page: 11301
  ident: CR61
  article-title: A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor
  publication-title: J Am Chem Soc
  doi: 10.1021/ja072157y
  contributor:
    fullname: Raleigh
– volume: 10
  start-page: 345
  issue: 5
  year: 2010
  end-page: 352
  ident: CR1
  article-title: Thierry Wurch, Christian Bailly, and Nathalie Corvaia, Strategies and challenges for the next generation of therapeutic antibodies
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2747
  contributor:
    fullname: Beck
– volume: 22
  start-page: 1542
  issue: 11
  year: 2013
  end-page: 1551
  ident: CR50
  article-title: Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress
  publication-title: Protein Sci
  doi: 10.1002/pro.2340
  contributor:
    fullname: Tsumoto
– volume: 86
  start-page: 3468
  issue: 7
  year: 2014
  end-page: 3475
  ident: CR15
  article-title: Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling
  publication-title: Anal Chem
  doi: 10.1021/ac404130a
  contributor:
    fullname: Liu
– volume: 89
  start-page: 11839
  issue: 21
  year: 2017
  ident: CR21
  article-title: Multivariate analysis of two-dimensional 1H, 13C methyl NMR spectra of monoclonal antibody therapeutics to facilitate assessment of higher order structure
  publication-title: Anal Chem
  doi: 10.1021/acs.analchem.7b03571
  contributor:
    fullname: Marino
– volume: 194
  start-page: 5497
  year: 2015
  end-page: 5508
  ident: CR4
  article-title: Fc engineering of human IgG1 for altered binding to the neonatal fc receptor affects fc effector functions
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1401218
  contributor:
    fullname: Grevys
– volume: 103
  start-page: 445
  issue: 2
  year: 2014
  end-page: 455
  ident: CR6
  article-title: Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23827
  contributor:
    fullname: Friess
– volume: 33
  start-page: 462
  issue: 2
  year: 2016
  end-page: 475
  ident: CR22
  article-title: 2D 1 H N, 15 N correlated NMR methods at natural abundance for obtaining structural maps and statistical comparability of monoclonal antibodies
  publication-title: Pharm Res
  doi: 10.1007/s11095-015-1802-3
  contributor:
    fullname: Marino
– volume: 136
  start-page: 311
  issue: 2
  year: 1981
  end-page: 315
  ident: CR58
  article-title: α-Lactalbumin: compact state with fluctuating tertiary structure?
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(81)80642-4
  contributor:
    fullname: Ptitsyn
– volume: 97
  start-page: 8340
  issue: 15
  year: 2000
  end-page: 8345
  ident: CR59
  article-title: NMR structures of three single-residue variants of the human prion protein
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.97.15.8340
  contributor:
    fullname: Wüthrich
– volume: 155
  start-page: 63
  issue: 1
  year: 2013
  end-page: 71
  ident: CR63
  article-title: Intermolecular interactions and conformation of antibody dimers present in IgG1 biopharmaceuticals
  publication-title: The Journal of Biochemistry
  doi: 10.1093/jb/mvt095
  contributor:
    fullname: Arisaka
– volume: 9
  start-page: 767
  issue: 10
  year: 2010
  end-page: 774
  ident: CR2
  article-title: Development trends for human monoclonal antibody therapeutics
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3229
  contributor:
    fullname: Reichert
– volume: 6
  start-page: 32201
  year: 2016
  ident: CR23
  article-title: Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies
  publication-title: Sci Rep
  doi: 10.1038/srep32201
  contributor:
    fullname: Plavec
– volume: 110
  start-page: 12867
  issue: 32
  year: 2013
  end-page: 12874
  ident: CR19
  article-title: NMR paves the way for atomic level descriptions of sparsely populated, transiently formed biomolecular conformers. NMR paves the way for atomic level descriptions of sparsely populated, transiently formed biomolecular conformers
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.1305688110
  contributor:
    fullname: Kay
– volume: 56
  start-page: 131
  issue: 1
  year: 2013
  end-page: 139
  ident: CR31
  article-title: IgG2 fc structure and the dynamic features of the IgG CH 2–CH 3 interface
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2013.03.018
  contributor:
    fullname: Gilliland
– ident: CR3
– volume: 112
  start-page: 326
  issue: 4
  year: 2011
  end-page: 332
  ident: CR7
  article-title: Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition
  publication-title: J Biosci Bioeng
  doi: 10.1016/j.jbiosc.2011.06.017
  contributor:
    fullname: Fukui
– volume: 78
  start-page: 394
  issue: 1
  year: 2000
  end-page: 404
  ident: CR11
  article-title: The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein
  publication-title: Biophysical Journal
  doi: 10.1016/S0006-3495(00)76602-1
  contributor:
    fullname: Norde
– volume: 106
  start-page: 3486
  year: 2017
  end-page: 3498
  ident: CR29
  article-title: Effect of Polysorbate 20 and Polysorbate 80 on the higher-order structure of a monoclonal antibody and its fab and fc fragments probed using 2D nuclear magnetic resonance spectroscopy
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2017.08.011
  contributor:
    fullname: Mallela
– ident: CR52
– volume: 98
  start-page: 3013
  issue: 9
  year: 2009
  end-page: 3030
  ident: CR55
  article-title: Elucidation of two major aggregation pathways in an IgG2 antibody
  publication-title: J Pharm Sci
  doi: 10.1002/jps.21514
  contributor:
    fullname: Jacob
– volume: 104
  start-page: 4546
  year: 1982
  end-page: 4559
  ident: CR38
  article-title: Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity
  publication-title: J Am Chem Soc
  doi: 10.1021/ja00381a009
  contributor:
    fullname: Szabo
– volume: 424
  start-page: 805
  issue: 6950
  year: 2003
  ident: CR62
  article-title: Rationalization of the effects of mutations on peptide and protein aggregation rates
  publication-title: Nature
  doi: 10.1038/nature01891
  contributor:
    fullname: Dobson
– volume: 20
  start-page: 6842
  issue: 24
  year: 1981
  end-page: 6852
  ident: CR33
  article-title: Segmental flexibility of immunoglobulin G antibody molecules in solution: a new interpretation
  publication-title: Biochemistry
  doi: 10.1021/bi00527a016
  contributor:
    fullname: Schumaker
– volume: 325
  start-page: 979
  issue: 5
  year: 2003
  end-page: 989
  ident: CR39
  article-title: Structural analysis of human IgG-fc glycoforms reveals a correlation between glycosylation and structural integrity
  publication-title: J Mol Biol
  doi: 10.1016/S0022-2836(02)01250-0
  contributor:
    fullname: Sondermann
– volume: 52
  start-page: 3376
  issue: 19
  year: 2013
  end-page: 3389
  ident: CR17
  article-title: Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody
  publication-title: Biochemistry
  doi: 10.1021/bi400232p
  contributor:
    fullname: Weis
– volume: 6
  start-page: 38
  issue: 1
  year: 2010
  end-page: 44
  ident: CR40
  article-title: Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies
  publication-title: Biotechnology Journal
  doi: 10.1002/biot.201000091
  contributor:
    fullname: Trout
– volume: 9
  start-page: 696
  year: 2012
  end-page: 707
  ident: CR5
  article-title: Advancements in high throughput biophysical technologies: applications for characterization and screening during early formulation development of monoclonal antibodies
  publication-title: Mol Pharm
  doi: 10.1021/mp200404c
  contributor:
    fullname: He
– volume: 97
  start-page: 3494
  issue: 9
  year: 2008
  end-page: 3517
  ident: CR10
  article-title: The complex inter-relationships between protein flexibility and stability
  publication-title: J Pharm Sci
  doi: 10.1002/jps.21269
  contributor:
    fullname: Middaugh
– volume: 34
  start-page: 601
  year: 2009
  end-page: 611
  ident: CR37
  article-title: Observing biological dynamics at atomic resolution using NMR
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2009.07.004
  contributor:
    fullname: Kay
– volume: 56
  start-page: 131
  year: 2013
  end-page: 139
  ident: CR46
  article-title: IgG2 fc structure and the dynamic features of the IgG CH2–CH3 interface
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2013.03.018
  contributor:
    fullname: Gilliland
– volume: 46
  start-page: 1750
  issue: 8
  year: 2009
  end-page: 1755
  ident: CR9
  article-title: Structural characterization of a human fc fragment engineered for extended serum half-life
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2009.01.026
  contributor:
    fullname: Dall’Acqua
– volume: 19
  start-page: 1191
  issue: 6
  year: 2010
  end-page: 1204
  ident: CR12
  article-title: The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies
  publication-title: Protein Sci
  doi: 10.1002/pro.396
  contributor:
    fullname: Latypov
– volume: 104
  start-page: 4546
  year: 1982
  ident: 2500_CR38
  publication-title: J Am Chem Soc
  doi: 10.1021/ja00381a009
  contributor:
    fullname: G Lipari
– volume: 6
  start-page: 32201
  year: 2016
  ident: 2500_CR23
  publication-title: Sci Rep
  doi: 10.1038/srep32201
  contributor:
    fullname: B Japelj
– volume: 6
  start-page: 38
  issue: 1
  year: 2010
  ident: 2500_CR40
  publication-title: Biotechnology Journal
  doi: 10.1002/biot.201000091
  contributor:
    fullname: Veysel Kayser
– volume: 56
  start-page: 131
  year: 2013
  ident: 2500_CR46
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2013.03.018
  contributor:
    fullname: A Teplyakov
– ident: 2500_CR52
  doi: 10.1016/j.str.2018.03.017
– volume: 106
  start-page: 1508
  issue: 6
  year: 2017
  ident: 2500_CR65
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2017.02.007
  contributor:
    fullname: J Arora
– volume: 31
  start-page: 1189
  issue: 10
  year: 1991
  ident: 2500_CR32
  publication-title: Biopolymers
  doi: 10.1002/bip.360311007
  contributor:
    fullname: H Kessler
– volume: 194
  start-page: 5497
  year: 2015
  ident: 2500_CR4
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1401218
  contributor:
    fullname: A Grevys
– volume: 286
  start-page: 1421
  issue: 5
  year: 1999
  ident: 2500_CR34
  publication-title: J Mol Biol
  doi: 10.1006/jmbi.1998.2556
  contributor:
    fullname: MK Boehm
– volume: 47
  start-page: 5088
  year: 2008
  ident: 2500_CR41
  publication-title: Biochemistry
  doi: 10.1021/bi702238b
  contributor:
    fullname: D Liu
– volume: 312
  start-page: 224
  year: 2006
  ident: 2500_CR42
  publication-title: Science
  doi: 10.1126/science.1124964
  contributor:
    fullname: A Mittermaier
– volume: 48
  start-page: 119
  issue: 1
  year: 2008
  ident: 2500_CR51
  publication-title: J Chem Inf Model
  doi: 10.1021/ci700237g
  contributor:
    fullname: B Folch
– volume: 136
  start-page: 311
  issue: 2
  year: 1981
  ident: 2500_CR58
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(81)80642-4
  contributor:
    fullname: DA Dolgikh
– volume: 241
  start-page: 3
  year: 2014
  ident: 2500_CR36
  publication-title: J Magn Reson
  doi: 10.1016/j.jmr.2014.01.008
  contributor:
    fullname: AG Palmer III
– volume: 19
  start-page: 1191
  issue: 6
  year: 2010
  ident: 2500_CR12
  publication-title: Protein Sci
  doi: 10.1002/pro.396
  contributor:
    fullname: SLH Chen
– volume: 106
  start-page: 3486
  year: 2017
  ident: 2500_CR29
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2017.08.011
  contributor:
    fullname: SM Singh
– volume: 588
  start-page: 936
  issue: 6
  year: 2014
  ident: 2500_CR53
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2014.01.051
  contributor:
    fullname: H Wu
– volume: 355
  start-page: 751
  issue: 3
  year: 2007
  ident: 2500_CR24
  publication-title: Biochemical and biophysical research communications, 2007
  doi: 10.1016/j.bbrc.2007.02.042
  contributor:
    fullname: E Garber
– volume: 3
  start-page: 517
  year: 1982
  ident: 2500_CR26
  publication-title: FEBS J
  contributor:
    fullname: VM Tischenko
– volume: 103
  start-page: 445
  issue: 2
  year: 2014
  ident: 2500_CR6
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23827
  contributor:
    fullname: T Menzen
– volume: 19
  start-page: 826
  issue: 4
  year: 2010
  ident: 2500_CR16
  publication-title: Protein Sci
  doi: 10.1002/pro.362
  contributor:
    fullname: W Burkitt
– volume: 101
  start-page: 1678
  issue: 5
  year: 2012
  ident: 2500_CR28
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23056
  contributor:
    fullname: E Sahin
– volume: 89
  start-page: 11839
  issue: 21
  year: 2017
  ident: 2500_CR21
  publication-title: Anal Chem
  doi: 10.1021/acs.analchem.7b03571
  contributor:
    fullname: LW Arbogast
– volume: 20
  start-page: 6842
  issue: 24
  year: 1981
  ident: 2500_CR33
  publication-title: Biochemistry
  doi: 10.1021/bi00527a016
  contributor:
    fullname: DC Hanson
– volume: 42
  start-page: 2363
  year: 2003
  ident: 2500_CR57
  publication-title: Biochemistry
  doi: 10.1021/bi026364g
  contributor:
    fullname: A Kjellsson
– volume: 87
  start-page: 3556
  issue: 7
  year: 2015
  ident: 2500_CR20
  publication-title: Anal Chem
  doi: 10.1021/ac504804m
  contributor:
    fullname: LW Arbogast
– volume: 22
  start-page: 1542
  issue: 11
  year: 2013
  ident: 2500_CR50
  publication-title: Protein Sci
  doi: 10.1002/pro.2340
  contributor:
    fullname: T Ito
– volume: 78
  start-page: 394
  issue: 1
  year: 2000
  ident: 2500_CR11
  publication-title: Biophysical Journal
  doi: 10.1016/S0006-3495(00)76602-1
  contributor:
    fullname: Arnoldus W.P. Vermeer
– volume: 52
  start-page: 3376
  issue: 19
  year: 2013
  ident: 2500_CR17
  publication-title: Biochemistry
  doi: 10.1021/bi400232p
  contributor:
    fullname: R Majumdar
– volume: 56
  start-page: 131
  issue: 1
  year: 2013
  ident: 2500_CR31
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2013.03.018
  contributor:
    fullname: A Teplyakov
– volume: 107
  start-page: 559
  year: 2018
  ident: 2500_CR60
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2017.10.010
  contributor:
    fullname: SE Pace
– volume: 97
  start-page: 8340
  issue: 15
  year: 2000
  ident: 2500_CR59
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.97.15.8340
  contributor:
    fullname: L Calzolai
– volume: 10
  start-page: 345
  issue: 5
  year: 2010
  ident: 2500_CR1
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2747
  contributor:
    fullname: A Beck
– volume: 98
  start-page: 3013
  issue: 9
  year: 2009
  ident: 2500_CR55
  publication-title: J Pharm Sci
  doi: 10.1002/jps.21514
  contributor:
    fullname: N Buren Van
– volume: 129
  start-page: 11300
  issue: 37
  year: 2007
  ident: 2500_CR61
  publication-title: J Am Chem Soc
  doi: 10.1021/ja072157y
  contributor:
    fullname: A Abedini
– volume: 81
  start-page: 2644
  issue: 7
  year: 2009
  ident: 2500_CR13
  publication-title: Anal Chem
  doi: 10.1021/ac802575y
  contributor:
    fullname: D Houde
– volume: 9
  start-page: 257
  year: 2015
  ident: 2500_CR44
  publication-title: Biomolecular NMR assignments
  doi: 10.1007/s12104-014-9586-7
  contributor:
    fullname: H Yagi
– volume: 328
  start-page: 98
  year: 2010
  ident: 2500_CR45
  publication-title: Science
  doi: 10.1126/science.1184991
  contributor:
    fullname: TL Religa
– volume: 12
  start-page: 1005
  year: 2015
  ident: 2500_CR64
  publication-title: Mol Pharm
  doi: 10.1021/mp400666b
  contributor:
    fullname: ML Brader
– ident: 2500_CR3
  doi: 10.1080/19420862.2016.1269580
– volume: 325
  start-page: 979
  issue: 5
  year: 2003
  ident: 2500_CR39
  publication-title: J Mol Biol
  doi: 10.1016/S0022-2836(02)01250-0
  contributor:
    fullname: S Krapp
– volume: 33
  start-page: 462
  issue: 2
  year: 2016
  ident: 2500_CR22
  publication-title: Pharm Res
  doi: 10.1007/s11095-015-1802-3
  contributor:
    fullname: LW Arbogast
– volume: 34
  start-page: 601
  year: 2009
  ident: 2500_CR37
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2009.07.004
  contributor:
    fullname: AK Mittermaier
– volume: 40
  start-page: 2743
  issue: 9
  year: 2001
  ident: 2500_CR48
  publication-title: Biochemistry
  doi: 10.1021/bi002898a
  contributor:
    fullname: JH Viles
– volume: 112
  start-page: 326
  issue: 4
  year: 2011
  ident: 2500_CR7
  publication-title: J Biosci Bioeng
  doi: 10.1016/j.jbiosc.2011.06.017
  contributor:
    fullname: H Nishi
– volume: 97
  start-page: 3494
  issue: 9
  year: 2008
  ident: 2500_CR10
  publication-title: J Pharm Sci
  doi: 10.1002/jps.21269
  contributor:
    fullname: TJ Kamerzell
– volume: 28
  start-page: 8588
  issue: 21
  year: 1989
  ident: 2500_CR27
  publication-title: Biochemistry
  doi: 10.1021/bi00447a048
  contributor:
    fullname: JF Brandts
– volume: 102
  start-page: 2136
  issue: 7
  year: 2013
  ident: 2500_CR18
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23543
  contributor:
    fullname: P Manikwar
– volume: 12
  start-page: 601
  issue: 34
  year: 2009
  ident: 2500_CR47
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2009.07.004
  contributor:
    fullname: AK Mittermaier
– volume: 9
  start-page: 767
  issue: 10
  year: 2010
  ident: 2500_CR2
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3229
  contributor:
    fullname: AL Nelson
– volume: 385
  start-page: 787
  issue: 6619
  year: 1997
  ident: 2500_CR56
  publication-title: Nature
  doi: 10.1038/385787a0
  contributor:
    fullname: DR Booth
– volume: 9
  start-page: 696
  year: 2012
  ident: 2500_CR5
  publication-title: Mol Pharm
  doi: 10.1021/mp200404c
  contributor:
    fullname: HS Samra
– volume: 110
  start-page: 12867
  issue: 32
  year: 2013
  ident: 2500_CR19
  publication-title: Proc Natl Acad Sci
  doi: 10.1073/pnas.1305688110
  contributor:
    fullname: A Sekhar
– volume: 155
  start-page: 63
  issue: 1
  year: 2013
  ident: 2500_CR63
  publication-title: The Journal of Biochemistry
  doi: 10.1093/jb/mvt095
  contributor:
    fullname: T Iwura
– volume: 140
  start-page: 4774
  issue: 14
  year: 2018
  ident: 2500_CR43
  publication-title: J Am Chem Soc
  doi: 10.1021/jacs.8b00931
  contributor:
    fullname: JL Kitevski-LeBlanc
– volume: 424
  start-page: 805
  issue: 6950
  year: 2003
  ident: 2500_CR62
  publication-title: Nature
  doi: 10.1038/nature01891
  contributor:
    fullname: F Chiti
– volume: 11
  start-page: 1869
  year: 2014
  ident: 2500_CR49
  publication-title: Mol Pharm
  doi: 10.1021/mp500005v
  contributor:
    fullname: BS Moorthy
– volume: 46
  start-page: 1750
  issue: 8
  year: 2009
  ident: 2500_CR9
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2009.01.026
  contributor:
    fullname: V Oganesyan
– volume: 32
  start-page: 372
  issue: 7
  year: 2014
  ident: 2500_CR54
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2014.05.005
  contributor:
    fullname: CJ Roberts
– volume: 97
  start-page: 1414
  issue: 4
  year: 2008
  ident: 2500_CR25
  publication-title: J Pharm Sci
  doi: 10.1002/jps.21104
  contributor:
    fullname: RM Ionescu
– volume: 134
  start-page: 6365
  year: 2012
  ident: 2500_CR35
  publication-title: J Am Chem Soc
  doi: 10.1021/ja300265w
  contributor:
    fullname: P Robustelli
– volume: 5
  start-page: 219
  issue: 2
  year: 2013
  ident: 2500_CR14
  publication-title: Mabs
  doi: 10.4161/mabs.23532
  contributor:
    fullname: RJ Rose
– volume: 7
  start-page: 84
  issue: 1
  year: 2015
  ident: 2500_CR8
  publication-title: MAbs
  doi: 10.4161/19420862.2014.985494
  contributor:
    fullname: R Majumdar
– volume: 86
  start-page: 3468
  issue: 7
  year: 2014
  ident: 2500_CR15
  publication-title: Anal Chem
  doi: 10.1021/ac404130a
  contributor:
    fullname: A Zhang
– volume: 79
  start-page: 2150
  issue: 4
  year: 2000
  ident: 2500_CR30
  publication-title: Biophys J
  doi: 10.1016/S0006-3495(00)76462-9
  contributor:
    fullname: AW Vermeer
SSID ssj0008194
Score 2.3717318
Snippet Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common...
Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common approach...
Purpose Fc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common...
PurposeFc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common...
PURPOSEFc domains are an integral component of monoclonal antibodies (mAbs) and Fc-based fusion proteins. Engineering mutations in the Fc domain is a common...
SourceID proquest
gale
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 220
SubjectTerms Amino acids
Analysis
Biochemistry
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Biomedicine
DNA fingerprinting
Fc receptors
Fingerprinting
Fragmentation
Fragments
Glycosylation
Health aspects
Heat measurement
Homology
Investigations
Medical Law
Melt temperature
Monoclonal antibodies
Mutation
NMR
Nuclear magnetic resonance
Pharmacology/Toxicology
Pharmacy
Proteins
Research Paper
Shelf life
Storage stability
SummonAdditionalLinks – databaseName: Proquest Health & Medical Complete
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7S9JJL6Sut27SoUBJII2pZWls-laXpEgIte0hgexKWLC0LiZ1knUP-fWf8WHcD7c2gpzWj0XyahwA-e-l80DrlNlGSqzQo_Mokt66wthSZtoGikX_-Ss8u1flisugv3Na9W-UgE1tBXdaO7si_IlBJKLOhyr_d3HJ6NYqsq_0TGk_gKZam5NKVLTaAi067Nn0UtsJdr8Rg1WxD50RMsckC-WQSx1xvnUuPpfNfx9Mje2l7DM2ew7Nef2TTjuAvYMdXL-Fw3iWgfjhhF2M81fqEHbL5mJr64RX8nlPapWrJKNBvCFvE7k4H7wxWBzZz7LS-LlbVmq0qNl0iIl-2FTm2rjxDMVC7q7bdtGpWtiZHxNdwOftx8f2M948rcIdKT8NxIX0gUIqSF0GdLLVQZYHgEIlUeERlpctIHxHahzwtxKRwwQelsqATV9pE7sNuhYO-BZYhaHNWBC_igOVZrmOby9IpqbTNbYjgeFhac9Pl0DBjtmSig0E6GKKD0REc0eIb2l_NXeGKPkwAh6JMVWaakRGb7K0RHGzVxH3htosH8pl-X67NyEURfNoUU0vyNat8fd_VQSUHcWEEbzqyb6YtCYLJiYjgy8AHY-f__Kd3_5_Ke9hLiBHbCMcD2G3u7v0HVHUa-7Hl5z82dPlK
  priority: 102
  providerName: ProQuest
Title Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies
URI https://link.springer.com/article/10.1007/s11095-018-2500-8
https://www.ncbi.nlm.nih.gov/pubmed/30255351
https://www.proquest.com/docview/2112047249
https://search.proquest.com/docview/2112613259
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_t44UXxDeBURkJDQkWFMdO7TwG1jKBmCq0St1TFDt2VQ0StGYP---5S5qGTvDAUyL5bCc-n32_nO8XgDdOWOe1HocmliKUYy_xTonQ2MKYkittPGUjfzsfn83ll0Wy2IN4--miuvrQRyTbhXrIdeMRJRNzVGwSRaHeh8OE2NBwDs_jbLv64g7XUkapWKKlS95HMv_WxM5edHdF_mNLuhMjbbee6QO4v_EZWdYp-SHsueoRHM860unbE3Yx5FCtT9gxmw101LeP4XJGVEvVklFyX5-qiM2d9icyWO3Z1LLT-mexqtZsVbFsiSh82QqGWLtyDE2_tj_aelnVrExNhw-fwHw6ufh0Fm5-qBBadHSaEKGW8wREcbVFICdKzWVZICBExRQOkVhpFfkgXDufjgueFNY7L6XyOralicVTOKiw0-fAFAI1a7h3PPJYrlIdmVSUVgqpTWp8AO_6oc1_dbwZ-cCQTHrIUQ856SHXAbylwc_Jpprrwhab1ADsitip8kxR4JpirAEc7UiiLdjd4l59-cYW1zlC3Jg4MWUawOttMdWk82WVq286GXRsEAsG8KxT-_axBcEukfAA3vfzYGj8n-_04r-kX8K9mOZlm-R4BAfN9Y17hd5OY0awrxZqBIfZ58uvE7x-nJzPvo_aSf8bjSv5hA
link.rule.ids 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,41093,41535,42162,42604,43322,43817,52123,52246,74073,74630
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BOcAF8SZQwEioSFCrcezdOCe0oqwWaKs9bKXlZMWOvVoJktJND_33zOSxYSvBLZIfSTzj8Xwez2eAd146H7Qec5soydU4KHxKJbcut7YQqbaBspFPz8azc_VtOVp2G26b7lhlbxMbQ11UjvbIjxCoJMRsqLJPF7853RpF0dXuCo3bcId4uOgGg3S5BVy02jX0UdgKZ70SfVSzSZ0TMeUmC9STURxzvbMu3bTOfy1PN-KlzTI0fQD3O_-RTVqBP4RbvnwEB_OWgPr6kC2GfKrNITtg84Ga-vox_JgT7VK5YpTo16ctYnfH_ekMVgU2dey4-pWvyw1bl2yyQkS-aipybF16hmagcj-bdpOyXtuKDiI-gfPpl8XnGe8uV-AOnZ6a40D6QKAULS-COllooYocwSEKKfeIygqXkj8itA_ZOBej3AUflEqDTlxhE_kU9kp86XNgKYI2Z0XwIg5YnmY6tpksnJJK28yGCD70Q2suWg4NM7AlkxwMysGQHIyO4D0NvqH5VV_mLu_SBPBVxFRlJikFsSneGsH-Tk2cF263uBef6eblxgxaFMHbbTG1pLNmpa-u2jro5CAujOBZK_btZ0uCYHIkIvjY68HQ-T__6cX_P-UN3J0tTk_Mydez7y_hXkJK2WQ77sNefXnlX6HbU9vXjW7_Af_r_DE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwEB7BVkK8IG5SChgJFQkaNY69ifOEFrarcq1WqJXKkxU79molSNpu-tB_z0yODVsJ3iL5SjzjmfkyhwHeOGGdVyoJTSxFKBMv8SkVobG5MQVPlfGUjfx9nhyfyi9n47Mu_mndhVX2MrER1EVl6R_5IQKVmCobyuzQd2ERi-nsw_lFSDdIkae1u07jNuykMhHRCHY-Hs0XPzZyGXVfU0wK50AZIHnv42wS6XhEmcocuWYcRaHa0lI3ZfVfyuqG97RRSrP7cK-zJtmkJf8DuOXKh7C_aMtRXx-wkyG7an3A9tliKFR9_Qh-LqgIU7lklPbXJzHidNM-VoNVns0sm1a_81W5ZquSTZaIz5dNxxBHl46hUKjsr2bcpKxXpqKwxMdwOjs6-XQcdlcthBZNoDrEbXWeICrKYYR4olBcFjlCRSRZ7hCjFTYl64Qr57Mk5-PceuelTL2KbWFi8QRGJS76DFiKEM4a7h2PPLanmYpMJgorhVQmMz6Ad_3W6vO2ooYeaicTHTTSQRMdtArgLW2-ptNWX-Y275IGcCmqW6UnKbm0yfsawN5WTzwldru5J5_uTulaDzwVwOtNM42kyLPSVVdtHzR5ECUG8LQl--a1BQEyMeYBvO_5YJj8n9-0-_9XeQV3kLH1t8_zr8_hbkw82aQ-7sGovrxyL9AGqs3Ljrn_AG59Ad0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Probing+Conformational+Diversity+of+Fc+Domains+in+Aggregation-Prone+Monoclonal+Antibodies&rft.jtitle=Pharmaceutical+research&rft.au=Majumder%2C+Subhabrata&rft.au=Jones%2C+Michael+T.&rft.au=Kimmel%2C+Michael&rft.au=Alphonse+Ignatius%2C+Arun&rft.date=2018-11-01&rft.pub=Springer+US&rft.issn=0724-8741&rft.eissn=1573-904X&rft.volume=35&rft.issue=11&rft_id=info:doi/10.1007%2Fs11095-018-2500-8&rft.externalDocID=10_1007_s11095_018_2500_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0724-8741&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0724-8741&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0724-8741&client=summon